Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)

HKG:2315 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 6, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	42,507	23,585	3,395	4,785	10,245	-
Market Cap Growth	759.67%	594.71%	-29.05%	-53.29%	-	-
Enterprise Value	42,242	23,859	3,562	4,682	10,003	-
Last Close Price	49.30	35.30	8.50	11.98	25.65	-
PE Ratio	60.54	122.37	95.11	-	-	-
PS Ratio	23.93	15.37	3.25	6.06	16.97	-
PB Ratio	16.36	9.72	3.80	5.50	7.87	-
P/TBV Ratio	16.76	9.99	4.13	5.73	8.12	-
P/FCF Ratio	125.28	75.04	18.32	-	-	-
P/OCF Ratio	77.73	57.24	15.10	-	-	-
EV/Sales Ratio	23.78	15.55	3.41	5.93	16.57	-
EV/EBITDA Ratio	79.81	67.88	13.92	-	-	-
EV/EBIT Ratio	111.21	101.51	25.51	-	-	-
EV/FCF Ratio	124.49	75.91	19.23	-	-	-
Debt / Equity Ratio	0.44	0.27	0.68	0.69	0.36	0.07
Debt / EBITDA Ratio	2.13	1.70	2.14	-	-	-
Debt / FCF Ratio	3.33	2.07	3.28	-	-	-
Net Debt / Equity Ratio	-0.10	-0.46	0.20	0.14	-0.20	-0.39
Net Debt / EBITDA Ratio	-0.54	-3.17	0.69	-0.71	0.49	1.16
Net Debt / FCF Ratio	-0.79	-3.54	0.96	-0.54	0.42	0.86
Asset Turnover	0.51	0.45	0.40	0.27	0.21	0.15
Inventory Turnover	3.96	2.49	3.74	12.25	6.09	6.11
Quick Ratio	2.29	2.05	1.20	1.01	1.25	1.55
Current Ratio	2.70	2.31	1.53	1.25	1.52	1.96
Return on Equity (ROE)	18.25%	11.48%	4.12%	-39.45%	-50.12%	-40.27%
Return on Assets (ROA)	6.81%	4.30%	3.37%	-6.94%	-14.81%	-14.02%
Return on Invested Capital (ROIC)	19.81%	17.82%	10.76%	-31.99%	-71.53%	-76.89%
Return on Capital Employed (ROCE)	11.20%	7.60%	7.00%	-15.60%	-27.60%	-28.00%
Earnings Yield	0.78%	0.82%	1.05%	-8.82%	-6.64%	-
FCF Yield	0.80%	1.33%	5.46%	-4.68%	-6.00%	-
Payout Ratio	5.08%	8.69%	45.29%	-	-	-
Buyback Yield / Dilution	-2.01%	3.93%	-5.26%	-4.54%	-5.13%	-180.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.